Semaglutide is a GLP-1 receptor agonist that helps with weight loss by suppressing appetite, reducing hunger signals, and slowing stomach emptying to prolong satiety
Calibrate uses this data-driven approach to intervene with a course correction if the patient biological response does not match the expected curve
For example, in a study involving lab models exposed to toxins, enhanced GPx activity significantly reduced lipid damage, highlighting its protective prowess
Blood Sugar Control For people with type 2 diabetes, both oral and injectable GLP-1 medications can significantly improve blood sugar levels and lower A1C, which measures average blood glucose over the previous two to three months
Ngari MM, Iversen PO, Thitiri J, Mwalekwa L, Timbwa M, Fegan GW, et al
Since its discovery in 1984 by Svetlana Mosjov, GLP-1 and its analogs (such as semaglutide, liraglutide, and dulaglutide) have rapidly become cornerstone treatments for type 2 diabetes mellitus (T2DM) and obesity
